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Amyloid precursor protein (APP) is a transmembrane protein highly expressed in
neurons. The full-length protein has cell-adhesion and receptor-like properties, which
play roles in synapse formation and stability. Furthermore, APP can be cleaved by
several proteases into numerous fragments, many of which affect synaptic function
and stability. This review article focuses on the mechanisms of APP in structural spine
plasticity, which encompasses the morphological alterations at excitatory synapses.
These occur as changes in the number and morphology of dendritic spines,
which correspond to the postsynaptic compartment of excitatory synapses. Both
overexpression and knockout (KO) of APP lead to impaired synaptic plasticity. Recent
data also suggest a role of APP in the regulation of astrocytic D-serine homeostasis,
which in turn regulates synaptic plasticity.
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STRUCTURAL PLASTICITY
Structural synaptic plasticity refers to morphologically observable changes of synapses which
accompany the classical electrophysiological events during synaptic plasticity. Most prominent
among them are dynamic changes in the number and shape of dendritic spines, which correspond
to the postsynaptic compartment of glutamatergic excitatory synapses. Dendritic spines are small
(1–2 µm long) protrusions of the dendritic shaft, which receive excitatory synaptic input and
compartmentalize calcium (Majewska et al., 2000; Yuste and Bonhoeffer, 2001; Yuste, 2011)
and therefore dictate the biophysical characteristics of a postsynapse. They are fundamental
players in establishing and maintaining the neuronal network as well as other complex functions
such as learning and memory. Conventionally, dendritic spines are classified according to
their morphology into three different groups: thin spines, which are fine and long but have a
discernible head; stubby spines, with a large head and an indiscernible neck and mushroom
spines with big head and thin neck (Yuste and Bonhoeffer, 2004; Alvarez and Sabatini, 2007;
Herms and Dorostkar, 2016). Additionally, filopodia are very motile protrusions that can
transform themselves into mushroom or thin spines (Alvarez and Sabatini, 2007). However,
a STED and EM based study revealed a higher degree of heterogeneity of both spine size and
morphology (Tønnesen et al., 2014). These morphologies reflect different functional properties:
for example, thin spines are more dynamic and more plastic than mushroom and stubby
spines, which are thought to be more stable (Yuste and Bonhoeffer, 2001; Knott et al., 2006).
A fraction of spines are continuously retracted and newly formed, and this process, expressed as
turnover rate (TOR), is accelerated during learning and memory formation (Fu and Zuo, 2011).
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Dendritic spines were discovered by Ramon y Cajal, who used
Golgi’s silver staining method to visualize dendrites and their
processes (Yuste and Bonhoeffer, 2001). While essentially the
same technical approach is still used today, modern research on
spines is typically conducted on transgenic animals expressing
a fluorophore in a sparse subset of neurons (Feng et al., 2000).
This allows visualization of spines on confocal microscopes, and,
more importantly, in vivo observation of the dynamic changes
comprising structural plasticity.
AMYLOID PRECURSOR PROTEIN IS
A SYNAPTIC PROTEIN
Amyloid precursor protein (APP) is a member of a family
of conserved type I membrane proteins which also includes
APP like one protein (APLP1) and APP like two protein
(APLP2; Wasco et al., 1992, 1993; Slunt et al., 1994). The
major APP isoform expressed in neurons is 695 amino acids
long, while longer isoforms are expressed in other tissues.
Full-length APP consists of four main domains: the extracellular
domains E1 (Dahms et al., 2010) and E2; a transmembrane
sequence (Dulubova et al., 2004; Keil et al., 2004; Dahms
et al., 2012); and the APP intracellular domain (AICD; Kroenke
et al., 1997; Radzimanowski et al., 2008; Coburger et al., 2014;
Figure 1). APP can be cleaved by a large number of proteases,
which are grouped into α-, β- and γ-secretases, depending
on the cleavage site. However, proteases which cleave APP
outside these three sites also exist (Vella and Cappai, 2012;
Willem et al., 2015; Zhang et al., 2015; Baranger et al., 2016).
Depending on the combination of proteases which process
APP, a vast number of different cleavage products may be
generated, which have various biological properties (Nhan et al.,
2015; Andrew et al., 2016). Among them are, for instance,
amyloid β fragments which are generated by the action of β,
and γ-secretases and which are known to be involved in the
pathogenesis of Alzheimer’s disease. Other proteolytic products,
such as the soluble fragment sAPPα and CTFs have been
shown to be neuroprotective (Chasseigneaux and Allinquant,
2012; Hick et al., 2015; Andrew et al., 2016). Furthermore,
in vitro evidence suggests that CTFs induce axonal outgrowth
by interacting with G-protein αs subunits, which in turn activate
adenylyl cyclase/PKA-dependent pathways (Copenhaver and
Kögel, 2017), although these findings have not been corroborated
in vivo.
In the brain, APP reaches its highest expression level during
early postnatal development (from P1 to P36 in mice) and is
preferentially localized at pre- and postsynapses (De Strooper
and Annaert, 2000). During this period, synaptogenesis occurs
and neuronal connections are formed (Hoe et al., 2009; Wang
et al., 2009). Accordingly, many studies described putative roles
of APP in the modulation of neurite outgrowth and synaptic
connectivity (Moya et al., 1994; De Strooper and Annaert,
2000; Herms et al., 2004; Wang et al., 2009; Hoe et al., 2012;
Müller and Zheng, 2012; Weyer et al., 2014; Hick et al.,
2015). Synaptogenesis and neurite outgrowth may be mediated
by full-length APP, which has been shown to exhibit cell
adhesion- and receptor-like properties (Qiu et al., 1995; Ando
et al., 1999; Turner et al., 2003; Soba et al., 2005; Müller and
Zheng, 2012; Coburger et al., 2014; Deyts et al., 2016): there is
convincing evidence that two distinct extracellular E1 domains
from neighboring molecules of APP, APLP1 and APLP2 (Soba
et al., 2005; Baumkötter et al., 2012; Deyts et al., 2016) can
interact via their heparin binding domains (HBDs), and form
a so-called heparin cross-linked dimer (Coburger et al., 2014).
The interaction of the E2 domains with heparin cross-linked
dimers further strengthens the dimerization process (Wang et al.,
2009; Hoefgen et al., 2014). As APP is present both on pre-
and postsynaptic terminals, a dimerization across the synapse
may be relevant for synapse formation and stabilization (Wang
et al., 2009; Baumkötter et al., 2014; Stahl et al., 2014). Moreover,
the interaction of E1 and E2 domains with extracellular matrix
components, like collagen, heparin, laminin, glypican, F-spondin
and β1- integrin reinforces APP dimerization, and may further
modulate the stability or plasticity of dendritic spines (Beher
et al., 1996; Williamson et al., 1996; Rice et al., 2013; Wade et al.,
2013).
Furthermore, growth factors and receptor-like proteins have
been shown to interact with the APP-extracellular domains
(Reinhard et al., 2005; Coburger et al., 2014; Deyts et al.,
2016). Thus, activation of growth factor receptors could be an
alternative mode of action of how APP affects spine plasticity.
Additionally, the intra-cellular domain AICD itself may mediate
receptor-like activity (Cao and Südhof, 2001, 2004; McLoughlin
and Miller, 2008; Müller et al., 2008; Klevanski et al., 2015).
Here, an intracellular response is triggered by the interaction of
AICD-cleavage products with effector and adaptor proteins from
the cytosolic compartment (Okamoto et al., 1990; Timossi et al.,
2004; Deyts et al., 2012; Figure 1).
In addition to developmental processes, APP has also been
shown to be involved in synaptic plasticity of mature synapses.
For instance, some AICD-proteolytic products can be directly
translocated into the nucleus and activate several transcription
factors, like CP2/LSF/LBP1 or Tip60 (Müller et al., 2008;
Schettini et al., 2010; Pardossi-Piquard and Checler, 2012), which
are known to be involved in the regulation of dendritic spine
plasticity.
APP IS INVOLVED IN STRUCTURAL SPINE
PLASTICITY
Two main bodies of evidence support a role of APP in
structural plasticity. On one hand, overexpression of APP,
which is often used to model Alzheimer’s disease, may
alter dendritic spines independently of typical Alzheimer’s
disease pathology. These findings are described later in
this section. On the other hand, knockout (KO) of APP
alters spine dynamics: in the hippocampus, APP KO
causes a range of synaptic alterations, depending on the
model and paradigm studied. For instance, in cultured
hippocampal neurons of APP KO animals, we found enhanced
amplitudes of evoked AMPA- and NMDA-receptor-mediated
EPSCs, which were reduced by pre-conditioned wildtype
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FIGURE 1 | Schematic representation of amyloid precursor protein (APP) structure and function at synapses. The dimerization of APP as well as the
signal cascade triggered by APP intracellular domain (AICD) are important for the regulation of spine stability. Astrocytes play a role in the regulation of spine
dynamics via the calcium dependent release of the glio-transmitter D-serine. 1. Schematic representation of APP domain structure. From the N-terminal region; the
E1 domain formed by: heparin binding domain (HBD), growth factor like domain (GFLD) and cupper binding domain (CuBD). The E2 domain that includes the
heparin binding domain and the pentapetide sequence (RERMS). Aβ region and transmembrane region precede the AICD intracellular domain. 2, 3. Example of APP
dimerization occurring at the synapses and between two molecules of APP on the same neuron. The dimerization is stabilized by the formation of disulfide bridges
(SH-SH) highlighted in yellow. 4. Schematic representation of AICD intracellular pathway. Phosphorylated AICD interacts with JNK triggering cell death, with JIP
stimulating cell differentiation and with Fe65 or JIP to get transport into the nucleus and modulate gene transcription. 5. Representation of astrocytic D-serine
release. D-serine is stored inside vesicles. Upon increase of intracellular calcium these vesicles fuse with the cellular membrane releasing D-serine into the
extracellular space. The precise role played by APP is still not clear 6. D-serine together with Glutamate (Glu) activates NMDA receptors (NMDAR). NMDAR activation
leads to the increase expression of AMPA receptors (AMPAR) on the membrane and triggers the activation of transcriptional factors into the nucleus.
medium. Additionally, we found an increased density of
synaptophysin-positive presynaptic puncta (Priller et al.,
2006). The number of dendritic spines, in contrast was
reduced (Tyan et al., 2012) in APP KO neurons, while it
was increased in APP overexpressing neurons (Lee et al.,
2010). In organotypic slice cultures APP-KO neurons showed
a pronounced decrease in spine density and reductions in the
number of mushroom spines, which was rescued by sAPPα
expression (Weyer et al., 2014). These results suggest that
soluble sAPPα modulates synaptic function in the neonatal
hippocampus. A study in hippocampal slices of adult APP
KO mice found decreased paired-pulse facilitation in the
dentate gyrus, while granule cell excitatory transmission
was unaltered (Jedlicka et al., 2012). These contrasting
findings may be the result of region-specific differences
in APP expression in the hippocampus (Del Turco et al.,
2016).
We recently studied dendritic spines of layer V pyramidal
neurons of the somatosensory cortex in 4 month old
APP-KO×GFP-Mmice (Zou et al., 2016), which is accessible to
chronic in vivo imaging. The density and the TOR of dendritic
spines were monitored for a period of 9 weeks in comparison to
GFP-M control mice (Figure 2). No differences were detected
in the overall spine densities between the groups, whereas
the fate of individual spines over time exhibited significant
changes in their elimination and formation rates, resulting
in reduced spine TOR (Zou et al., 2016). Since an alteration
in spine plasticity is often correlated with alteration in spine
morphology, we performed morphological analyses and found
a decrease in the fraction of thin spines and an increase in
the fraction of mushroom spines (Zou et al., 2016). These
findings mirror the dynamic changes in TOR as thin spines
are typically less stable than mushroom or stubby spines. In an
earlier article (Bittner et al., 2009), in contrast, we had found an
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FIGURE 2 | Stimulation-induced synaptic plasticity is deficient in APP
knockout (KO) mice and can be restored upon D-serine
administration. (A) In vivo images of apical dendrites from layer V pyramidal
neurons in the somatosensory cortex of WT, APP KO and APP KO mice
treated with D-serine, before and after exposure to enriched environment (EE),
which broadly stimulates sensory and motor function. Scale bar, 10 µm.
(B) Statistical summary of alterations in relative spine density over time. WT
mice respond with increased spine density and turnover, while APP KO mice
do not. Treatment with D-serine restores EE-induced synaptic plasticity in APP
KO. (WT, n = 5; APP KO, n = 6; APP KO + D-serine, n = 4). Figured modified
from Zou et al. (2016).
increased number of spines in APP KO, while turnover was not
analyzed in detail. Two main factors may explain this apparent
discrepancy: first, the data from the 2009 article were recorded
almost a decade earlier, on an older generation multiphoton
microscope. Modern microscopes have become considerably
better at resolving thin spines. APP KO changes the morphology
from thin to mushroom spines, which are more voluminous
and thus easier to detect. Since thin spines used to be harder
to detect, the results may have been interpreted as an apparent
increase in spine densities. Second, the 2009 study used the
YFP-H mouse line to label neurons, while the 2016 study used
the GFP-M line. Although the populations of neurons which
are labeled in both lines overlap, they are not identical. Thus,
the subset of neurons analyzed in the earlier study may have
had a different response to APP KO or it may have had a
relatively higher fraction of thin spines, thus aggravating the first
factor.
In order to understand whether the reduced TOR in APP-KO
can be increased by physiological stimuli, we exposed APP KO
mice to enriched environment (EE) which enhances the spine
plasticity in several brain regions and increases TOR (Berman
et al., 1996; Kozorovitskiy et al., 2005; Nithianantharajah and
Hannan, 2006; Mora et al., 2007; Jung and Herms, 2014; Sale
et al., 2014). However, APP KO mice exposed to EE for 5 weeks
did not exhibit the physiological increase in spine density which
was observed inWT controls (Zou et al., 2016). Thus, loss of APP
leads to impaired adaptive spine plasticity (Figure 2).
In order to elucidate which domain of APP modulates
dendritic spine plasticity, spine density and TOR were
investigated in APP-∆CT15 mice (Ring et al., 2007). These
mice express a truncated form of APP, lacking 15 amino acids at
the C-terminus, which correspond to the AICD. It was shown
that several other phenotypes of APP-KO mice were rescued
in APP-∆CT15 mice, such as growth rates, brain weight, grip
strength, locomotor alterations and spatial learning associated
with long term potentiation (LTP) impairment in aged mice
(Müller et al., 1994; Zheng et al., 1995; Dawson et al., 1999;
Magara et al., 1999; Ring et al., 2007).
To further elucidate the role of APP in spine dynamics, our
team conducted a study on 4–5 month old APP 23-GFP-M
mice by 2-photon microscopy in vivo. APP 23-GFP-M mice
overexpress human APP (isoform 751) with the Swedish
(KM670/671NL) mutation under the murine Thy1 promoter
(Sturchler-Pierrat et al., 1997). This leads to the formation of
amyloid β deposits starting at 6 months of age and therefore
this mouse line is considered to be a model of amyloidosis.
However, our study revealed a significant decrease in dendritic
spine density of layer V neurons of the somatosensory cortex
(Zou et al., 2015) before the appearance of Aβ plaques, which was
correlated with the amount of intracellular APP accumulating
in neurons. Intracellular APP accumulation has been shown to
mediate neuro- and synaptotoxicity in a number of publications
(Neve et al., 1992; Fukuchi et al., 1994; Oster-Granite et al.,
1996; Lu et al., 2003). Thus, it is crucial to distinguish between
these different causes of synaptotoxicity when studying models
of amyloidosis, as they do not all necessarily reflect human
disease.
APP REGULATES SPINE PLASTICITY BY
MODULATION OF ASTROCYTIC D-SERINE
An additional mechanism for APP-mediated spine-arrangement
is suggested by its modulation of astrocytic D-serine homeostasis,
which is a modulator of synaptic NMDA receptors (Engert
and Bonhoeffer, 1999; Hering and Sheng, 2001; Lai and Ip,
2013). The calcium-dependent astrocytic release of D-serine
modulates NMDA-dependent LTP (Henneberger et al., 2010).
It has been shown that full-length APP and its fragments
modulate D-serine secretion (Wu and Barger, 2004; Wu
et al., 2007) as well as astrocytic calcium homeostasis (Hamid
et al., 2007; Linde et al., 2011). More recently, biosensor
measurements in the cortex of 4–6 month old APP KO
mice revealed decreased extracellular D-serine levels, while
total D-serine was increased (Zou et al., 2016). These results
suggest an alteration of D-serine homeostasis in APP deficient
mice may underlie the altered regulation of spine dynamics.
Treatment with exogenous D-serine for 5 weeks, supplemented
in drinking water of standard housed and EE mice, restored
extracellular D-serine levels and normalized the concentrations
of total D-serine and L-serine in APP-KO brain (Zou
et al., 2016). Furthermore, the administration of D-serine
rescued the impaired dendritic structural plasticity in APP-KO
mice: D-serine treated APP-KO mice had restored spine
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dynamics under standard housing conditions. Moreover, upon
environmental enrichment, the fraction of thin spines was
enhanced, while fraction of mushrooms spines was decreased
(Figure 2). Although these data do not contest the synaptic role
played by APP, they suggest a new interaction between APP and
the D-serine homeostasis which is involved in spine dynamics
and plasticity.
CONCLUSIONS
Several mechanisms by which APPmaymodulate spine plasticity
have been identified (summarized in Figure 1): structural
properties of the full-length protein may help stabilizing
synapses, while binding of ligands to the extracellular part
may trigger intracellular cascades, similar to a classical receptor
molecules. Additionally, recent findings demonstrate that APP
modulates astrocytic D-serine homeostasis, which interacts with
NDMA receptors to modify synaptic function. Lastly, neurotoxic
and neuroprotective APP fragments may trigger or alleviate
pathophysiological mechanisms involved in neurodegenerative
diseases. Thus, APP seems to regulate synaptic plasticity at
several levels. Yet, the relative importance of each of these
mechanisms in physiology and disease remains to be elucidated.
AUTHOR CONTRIBUTIONS
EM and MMD wrote the review article, prepared figures.
JH wrote the review article.
ACKNOWLEDGMENTS
This work was funded by the European Commission within the
7th framework (Extrabrain–606950).
REFERENCES
Alvarez, V. A., and Sabatini, B. L. (2007). Anatomical and physiological plasticity
of dendritic spines. Annu. Rev. Neurosci. 30, 79–97. doi: 10.1146/annurev.
neuro.30.051606.094222
Ando, K., Oishi, M., Takeda, S., Iijima, K., Isohara, T., Nairn, A. C., et al. (1999).
Role of phosphorylation of Alzheimer’s amyloid precursor protein during
neuronal differentiation. J. Neurosci. 19, 4421–4427.
Andrew, R. J., Kellett, K. A. B., Thinakaran, G., and Hooper, N. M. (2016).
A greek tragedy: the growing complexity of alzheimer amyloid precursor
protein proteolysis. J. Biol. Chem. 291, 19235–19244. doi: 10.1074/jbc.R116.
746032
Baranger, K., Marchalant, Y., Bonnet, A. E., Crouzin, N., Carrete, A.,
Paumier, J.-M., et al. (2016).MT5-MMP is a new pro-amyloidogenic proteinase
that promotes amyloid pathology and cognitive decline in a transgenic
mouse model of Alzheimer’s disease. Cell. Mol. Life Sci. 73, 217–236.
doi: 10.1007/s00018-015-1992-1
Baumkötter, F., Schmidt, N., Vargas, C., Schilling, S., Weber, R., Wagner, K., et al.
(2014). Amyloid precursor protein dimerization and synaptogenic function
depend on copper binding to the growth factor-like domain. J. Neurosci. 34,
11159–11172. doi: 10.1523/JNEUROSCI.0180-14.2014
Baumkötter, F., Wagner, K., Eggert, S., Wild, K., and Kins, S. (2012).
Structural aspects and physiological consequences of APP/APLP trans-
dimerization. Exp. Brain Res. 217, 389–395. doi: 10.1007/s00221-011-
2878-6
Beher, D., Hesse, L., Masters, C. L., and Multhaup, G. (1996). Regulation of
amyloid protein precursor (APP) binding to collagen and mapping of the
binding sites on APP and collagen type I. J. Biol. Chem. 271, 1613–1620.
doi: 10.1074/jbc.271.3.1613
Berman, R. F., Hannigan, J. H., Sperry, M. A., and Zajac, C. S. (1996).
Prenatal alcohol exposure and the effects of environmental enrichment on
hippocampal dendritic spine density. Alcohol 13, 209–216. doi: 10.1016/0741-
8329(95)02049-7
Bittner, T., Fuhrmann, M., Burgold, S., Jung, C. K. E., Volbracht, C., Steiner, H.,
et al. (2009). γ-secretase inhibition reduces spine density in vivo via an
amyloid precursor protein-dependent pathway. J. Neurosci. 29, 10405–10409.
doi: 10.1523/JNEUROSCI.2288-09.2009
Cao, X., and Südhof, T. C. (2001). A transcriptionally correction
of transcriptively active complex of APP with Fe65 and histone
acetyltransferase Tip60. Science 293, 115–120. doi: 10.1126/science.10
58783
Cao, X., and Südhof, T. C. (2004). Dissection of amyloid-beta precursor protein-
dependent transcriptional transactivation. J. Biol. Chem. 279, 24601–24611.
doi: 10.1074/jbc.M402248200
Chasseigneaux, S., and Allinquant, B. (2012). Functions of Aβ, sAPPα and sAPPβ?
similarities and differences. J. Neurochem. 120, 99–108. doi: 10.1111/j.1471-
4159.2011.07584.x
Coburger, I., Hoefgen, S., and Than, M. E. (2014). The structural biology of the
amyloid precursor protein APP—a complex puzzle reveals its multi-domain
architecture. Biol. Chem. 395, 485–498. doi: 10.1515/hsz-2013-0280
Copenhaver, P. F., and Kögel, D. (2017). Role of APP interactions with
heterotrimeric G proteins: physiological functions and pathological
consequences. Front. Mol. Neurosci. 10:3. doi: 10.3389/fnmol.2017.00003
Dahms, S. O., Hoefgen, S., Roeser, D., Schlott, B., Gührs, K.-H., and Than, M. E.
(2010). Structure and biochemical analysis of the heparin-induced E1 dimer of
the amyloid precursor protein. Proc. Natl. Acad. Sci. U S A 107, 5381–5386.
doi: 10.1073/pnas.0911326107
Dahms, S. O., Könnig, I., Roeser, D., Gührs, K.-H., Mayer, M. C., Kaden, D.,
et al. (2012). Metal binding dictates conformation and function of the amyloid
precursor protein (APP) E2 domain. J. Mol. Biol. 416, 438–452. doi: 10.1016/j.
jmb.2011.12.057
Dawson, G. R., Seabrook, G. R., Zheng, H., Smith, D. W., Graham, S., O’Dowd, G.,
et al. (1999). Age-related cognitive deficits, impaired long-term potentiation
and reduction in synaptic marker density in mice lacking the beta-amyloid
precursor protein. Neuroscience 90, 1–13. doi: 10.1016/s0306-4522(98)
00410-2
De Strooper, B., and Annaert, W. (2000). Proteolytic processing and cell
biological functions of the amyloid precursor protein. J. Cell Sci. 113,
1857–1870.
Del Turco, D., Paul, M. H., Schlaudraff, J., Hick, M., Endres, K., Müller, U. C., et al.
(2016). Region-specific differences in amyloid precursor protein expression in
the mouse hippocampus. Front. Mol. Neurosci. 9:134. doi: 10.3389/fnmol.2016.
00134
Deyts, C., Thinakaran, G., and Parent, A. T. (2016). APP receptor? to be or not to
be. Trends Pharmacol. Sci. 37, 390–411. doi: 10.1016/j.tips.2016.01.005
Deyts, C., Vetrivel, K. S., Das, S., Shepherd, Y. M., Dupré, D. J., Thinakaran, G.,
et al. (2012). Novel GaS-protein signaling associated with membrane-tethered
amyloid precursor protein intracellular domain. J. Neurosci. 32, 1714–1729.
doi: 10.1523/JNEUROSCI.5433-11.2012
Dulubova, I., Ho, A., Huryeva, I., Südhof, T. C., and Rizo, J. (2004). Three-
dimensional structure of an independently folded extracellular domain
of human amyloid-beta precursor protein. Biochemistry 43, 9583–9588.
doi: 10.1021/bi049041o
Engert, F., and Bonhoeffer, T. (1999). Dendritic spine changes associated
with hippocampal long-term synaptic plasticity. Nature 399, 66–70.
doi: 10.1038/19978
Feng, G., Mellor, R. H., Bernstein, M., Keller-Peck, C., Nguyen, Q. T., Wallace, M.,
et al. (2000). Imaging neuronal subsets in transgenic mice expressing multiple
Frontiers in Molecular Neuroscience | www.frontiersin.org 5 May 2017 | Volume 10 | Article 136
Montagna et al. APP in Synaptic Plasticity
spectral variants of GFP. Neuron 28, 41–51. doi: 10.1016/S0896-6273(00)
00084-2
Fu, M., and Zuo, Y. (2011). Experience-dependent structural plasticity
in the cortex. Trends Neurosci. 34, 177–187. doi: 10.1016/j.tins.2011.
02.001
Fukuchi, K., Kunkel, D. D., Schwartzkroin, P. A., Kamino, K., Ogburn, C. E.,
Furlong, C. E., et al. (1994). Overexpression of a C-Terminal Portion of
the β-Amyloid Precursor Protein in Mouse Brains by Transplantation of
Transformed Neuronal Cells. Exp. Neurol. 127, 253–264. doi: 10.1006/exnr.
1994.1101
Hamid, R., Kilger, E., Willem, M., Vassallo, N., Kostka, M., Bornhövd, C.,
et al. (2007). Amyloid precursor protein intracellular domain modulates
cellular calcium homeostasis and ATP content. J. Neurochem. 102, 1264–1275.
doi: 10.1111/j.1471-4159.2007.04627.x
Henneberger, C., Papouin, T., Oliet, S. H. R., and Rusakov, D. A. (2010). Long-
term potentiation depends on release of D-serine from astrocytes. Nature 463,
232–236. doi: 10.1038/nature08673
Hering, H., and Sheng, M. (2001). Dendritic spines: structure, dynamics and
regulation. Nat. Rev. Neurosci. 2, 880–888. doi: 10.1038/35104061
Herms, J., and Dorostkar, M. M. (2016). Dendritic spine pathology
in neurodegenerative diseases. Annu. Rev. Pathol. 11, 221–250.
doi: 10.1146/annurev-pathol-012615-044216
Herms, J., Anliker, B., Heber, S., Ring, S., Fuhrmann, M., Kretzschmar, H., et al.
(2004). Cortical dysplasia resembling human type 2 lissencephaly in mice
lacking all three APP family members. EMBO J. 23, 4106–4115. doi: 10.1038/sj.
emboj.7600390
Hick, M., Herrmann, U., Weyer, S. W., Mallm, J.-P., Tschäpe, J.-A.,
Borgers, M., et al. (2015). Acute function of secreted amyloid precursor
protein fragment APPsα in synaptic plasticity. Acta Neuropathol. 129, 21–37.
doi: 10.1007/s00401-014-1368-x
Hoe, H.-S., Fu, Z., Makarova, A., Lee, J.-Y., Lu, C., Feng, L., et al. (2009). The effects
of amyloid precursor protein on postsynaptic composition and activity. J. Biol.
Chem. 284, 8495–8506. doi: 10.1074/jbc.M900141200
Hoe, H.-S., Lee, H.-K., and Pak, D. T. S. (2012). The upside of APP at synapses.
CNS Neurosci. Ther. 18, 47–56. doi: 10.1111/j.1755-5949.2010.00221.x
Hoefgen, S., Coburger, I., Roeser, D., Schaub, Y., Dahms, S. O., and Than, M. E.
(2014). Heparin induced dimerization of APP is primarily mediated by E1 and
regulated by its acidic domain. J. Struct. Biol. 187, 30–37. doi: 10.1016/j.jsb.
2014.05.006
Jedlicka, P., Owen, M., Vnencak, M., Tschäpe, J.-A., Hick, M., Müller, U. C., et al.
(2012). Functional consequences of the lack of amyloid precursor protein in the
mouse dentate gyrus in vivo. Exp. Brain Res. 217, 441–447. doi: 10.1007/s00221-
011-2911-9
Jung, C. K. E., and Herms, J. (2014). Structural dynamics of dendritic spines are
influenced by an environmental enrichment: an in vivo imaging study. Cereb.
Cortex 24, 377–384. doi: 10.1093/cercor/bhs317
Keil, C., Huber, R., Bode, W., and Than, M. E. (2004). Cloning, expression,
crystallization and initial crystallographic analysis of the C-terminal domain
of the amyloid precursor protein APP. Acta Crystallogr. D. Biol. Crystallogr. 60,
1614–1617. doi: 10.1107/s0907444904015343
Klevanski, M., Herrmann, U., Weyer, S. W., Fol, R., Cartier, N., Wolfer, D. P.,
et al. (2015). The APP intracellular domain is required for normal synaptic
morphology, synaptic plasticity and hippocampus-dependent behavior.
J. Neurosci. 35, 16018–16033. doi: 10.1523/JNEUROSCI.2009-15.2015
Knott, G. W., Holtmaat, A., Wilbrecht, L., Welker, E., and Svoboda, K. (2006).
Spine growth precedes synapse formation in the adult neocortex in vivo. Nat.
Neurosci. 9, 1117–1124. doi: 10.1038/nn1747
Kozorovitskiy, Y., Gross, C. G., Kopil, C., Battaglia, L., McBreen, M.,
Stranahan, A. M., et al. (2005). Experience induces structural and biochemical
changes in the adult primate brain. Proc. Natl. Acad. Sci. U S A 102,
17478–17482. doi: 10.1073/pnas.0508817102
Kroenke, C. D., Ziemnicka-Kotula, D., Xu, J., Kotula, L., and Palmer, A. G.
(1997). Solution conformations of a peptide containing the cytoplasmic domain
sequence of the beta amyloid precursor protein. Biochemistry 36, 8145–8152.
doi: 10.1021/bi9705669
Lai, K.-O., and Ip, N. Y. (2013). Structural plasticity of dendritic spines: the
underlying mechanisms and its dysregulation in brain disorders. Biochim.
Biophys. Acta 1832, 2257–2263. doi: 10.1016/j.bbadis.2013.08.012
Lee, K. J., Moussa, C. E. H., Lee, Y., Sung, Y., Howell, B. W., Turner, R. S.,
et al. (2010). Beta amyloid-independent role of amyloid precursor protein in
generation and maintenance of dendritic spines. Neuroscience 169, 344–356.
doi: 10.1016/j.neuroscience.2010.04.078
Linde, C. I., Baryshnikov, S. G., Mazzocco-Spezzia, A., and Golovina, V. A.
(2011). Dysregulation of Ca2+ signaling in astrocytes from mice lacking
amyloid precursor protein. Am. J. Physiol. Cell Physiol. 300, C1502–C1512.
doi: 10.1152/ajpcell.00379.2010
Lu, D. C., Soriano, S., Bredesen, D. E., and Koo, E. H. (2003). Caspase cleavage
of the amyloid precursor protein modulates amyloid β-protein toxicity.
J. Neurochem. 87, 733–741. doi: 10.1046/j.1471-4159.2003.02059.x
Magara, F., Müller, U., Li, Z. W., Lipp, H. P., Weissmann, C., Stagljar, M., et al.
(1999). Genetic background changes the pattern of forebrain commissure
defects in transgenic mice underexpressing the beta-amyloid-precursor
protein. Proc. Natl. Acad. Sci. U S A 96, 4656–4661. doi: 10.1073/pnas.96.
8.4656
Majewska, A., Tashiro, A., and Yuste, R. (2000). Regulation of spine calcium
dynamics by rapid spine motility. J. Neurosci. 20, 8262–8268.
McLoughlin, D. M., andMiller, C. C. J. (2008). The FE65 proteins and Alzheimer’s
disease. J. Neurosci. Res. 86, 744–754. doi: 10.1002/jnr.21532
Mora, F., Segovia, G., and del Arco, A. (2007). Aging, plasticity and environmental
enrichment: structural changes and neurotransmitter dynamics in several
areas of the brain. Brain Res. Rev. 55, 78–88. doi: 10.1016/j.brainresrev.2007.
03.011
Moya, K. L., Benowitz, L. I., Schneider, G. E., and Allinquant, B. (1994). The
amyloid precursor protein is developmentally regulated and correlated with
synaptogenesis. Dev. Biol. 161, 597–603. doi: 10.1006/dbio.1994.1055
Müller, T., Meyer, H. E., Egensperger, R., and Marcus, K. (2008). The
amyloid precursor protein intracellular domain (AICD) as modulator of gene
expression, apoptosis and cytoskeletal dynamics-relevance for Alzheimer’s
disease. Prog. Neurobiol. 85, 393–406. doi: 10.1016/j.pneurobio.2008.05.002
Müller, U. C., and Zheng, H. (2012). Physiological functions of APP family
proteins. Cold Spring Harb. Perspect. Med. 2:a006288. doi: 10.1101/cshperspect.
a006288
Müller, U., Cristina, N., Li, Z. W., Wolfer, D. P., Lipp, H. P., Rülicke, T., et al.
(1994). Behavioral and anatomical deficits in mice homozygous for a modified
beta-amyloid precursor protein gene. Cell 79, 755–765. doi: 10.1016/0092-
8674(94)90066-3
Neve, R. L., Kammesheidt, A., and Hohmann, C. F. (1992). Brain transplants
of cells expressing the carboxyl-terminal fragment of the Alzheimer amyloid
protein precursor cause specific neuropathology in vivo. Proc. Natl. Acad. Sci.
U S A 89, 3448–3452. doi: 10.1073/pnas.89.8.3448
Nhan, H. S., Chiang, K., and Koo, E. H. (2015). The multifaceted nature of
amyloid precursor protein and its proteolytic fragments: friends and foes. Acta
Neuropathol. 129, 1–19. doi: 10.1007/s00401-014-1347-2
Nithianantharajah, J., and Hannan, A. J. (2006). Enriched environments,
experience-dependent plasticity and disorders of the nervous system. Nat. Rev.
Neurosci. 7, 697–709. doi: 10.1038/nrn1970
Okamoto, T., Katada, T., Murayama, Y., Ui, M., Ogata, E., Nishimoto, I., et al.
(1990). A simple structure encodes G protein-activating function of the
IGF-II/mannose 6-phosphate receptor. Cell 62, 709–717. doi: 10.1016/0092-
8674(90)90116-v
Oster-Granite, M. L., McPhie, D. L., Greenan, J., and Neve, R. L. (1996). Age-
dependent neuronal and synaptic degeneration in mice transgenic for the C
terminus of the amyloid precursor protein. J. Neurosci. 16, 6732–6741.
Pardossi-Piquard, R., and Checler, F. (2012). The physiology of the β-amyloid
precursor protein intracellular domain AICD. J. Neurochem. 120, 109–124.
doi: 10.1111/j.1471-4159.2011.07475.x
Priller, C., Bauer, T., Mitteregger, G., Krebs, B., Kretzschmar, H. A., and Herms, J.
(2006). Synapse formation and function is modulated by the amyloid precursor
protein. J. Neurosci. 26, 7212–7221. doi: 10.1523/JNEUROSCI.1450-06.2006
Qiu,W. Q., Ferreira, A., Miller, C., Koo, E. H., and Selkoe, D. J. (1995). Cell-surface
beta-amyloid precursor protein stimulates neurite outgrowth of hippocampal
neurons in an isoform-dependent manner. J. Neurosci. 15, 2157–2167.
Radzimanowski, J., Simon, B., Sattler, M., Beyreuther, K., Sinning, I., and Wild, K.
(2008). Structure of the intracellular domain of the amyloid precursor protein
in complex with Fe65-PTB2. EMBO Rep. 9, 1134–1140. doi: 10.1038/embor.
2008.188
Frontiers in Molecular Neuroscience | www.frontiersin.org 6 May 2017 | Volume 10 | Article 136
Montagna et al. APP in Synaptic Plasticity
Reinhard, C., Hébert, S. S., andDe Strooper, B. (2005). The amyloid-beta precursor
protein: integrating structure with biological function. EMBO J. 24, 3996–4006.
doi: 10.1038/sj.emboj.7600860
Rice, H. C., Young-Pearse, T. L., and Selkoe, D. J. (2013). Systematic evaluation
of candidate ligands regulating ectodomain shedding of amyloid precursor
protein. Biochemistry 52, 3264–3277. doi: 10.1021/bi400165f
Ring, S., Weyer, S. W., Kilian, S. B., Waldron, E., Pietrzik, C. U., Filippov, M. A.,
et al. (2007). The secreted beta-amyloid precursor protein ectodomain
APPs alpha is sufficient to rescue the anatomical, behavioral and
electrophysiological abnormalities of APP-deficient mice. J. Neurosci. 27,
7817–7826. doi: 10.1523/JNEUROSCI.1026-07.2007
Sale, A., Berardi, N., and Maffei, L. (2014). Environment and brain plasticity:
towards an endogenous pharmacotherapy. Physiol. Rev. 94, 189–234.
doi: 10.1152/physrev.00036.2012
Schettini, G., Govoni, S., Racchi, M., and Rodriguez, G. (2010). Phosphorylation
of APP-CTF-AICD domains and interaction with adaptor proteins: signal
transduction and/or transcriptional role—relevance for Alzheimer pathology.
J. Neurochem. 115, 1299–1308. doi: 10.1111/j.1471-4159.2010.07044.x
Slunt, H. H., Thinakaran, G., Von Koch, C., Lo, A. C., Tanzi, R. E., and Sisodia, S. S.
(1994). Expression of a ubiquitous, cross-reactive homolog of the mouse
beta-amyloid precursor protein (APP). J. Biol. Chem. 269, 2637–2644.
Soba, P., Eggert, S., Wagner, K., Zentgraf, H., Siehl, K., Kreger, S., et al. (2005).
Homo- and heterodimerization of APP family members promotes intercellular
adhesion. EMBO J. 24, 3624–3634. doi: 10.1038/sj.emboj.7600824
Stahl, R., Schilling, S., Soba, P., Rupp, C., Hartmann, T., Wagner, K., et al. (2014).
Shedding of APP limits its synaptogenic activity and cell adhesion properties.
Front. Cell. Neurosci. 8:410. doi: 10.3389/fncel.2014.00410
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K. H., Mistl, C.,
Rothacher, S., et al. (1997). Two amyloid precursor protein transgenic mouse
models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. U S A 94,
13287–13292.
Timossi, C., Ortiz-Elizondo, C., Pineda, D. B., Dias, J. A., Conn, P. M., and
Ulloa-Aguirre, A. (2004). Functional significance of the BBXXB motif reversed
present in the cytoplasmic domains of the human follicle-stimulating hormone
receptor.Mol. Cell. Endocrinol. 223, 17–26. doi: 10.1016/j.mce.2004.06.004
Tønnesen, J., Katona, G., Rózsa, B., and Nägerl, U. V. (2014). Spine neck plasticity
regulates compartmentalization of synapses. Nat. Neurosci. 17, 678–685.
doi: 10.1038/nn.3682
Turner, P. R., O’Connor, K., Tate, W. P., and Abraham, W. C. (2003).
Roles of amyloid precursor protein and its fragments in regulating neural
activity, plasticity and memory. Prog. Neurobiol. 70, 1–32. doi: 10.1016/s0301-
0082(03)00089-3
Tyan, S.-H., Shih, A. Y.-J., Walsh, J. J., Maruyama, H., Sarsoza, F., Ku, L., et al.
(2012). Amyloid precursor protein (APP) regulates synaptic structure and
function.Mol. Cell. Neurosci. 51, 43–52. doi: 10.1016/j.mcn.2012.07.009
Vella, L. J., and Cappai, R. (2012). Identification of a novel amyloid precursor
protein processing pathway that generates secreted N-terminal fragments.
FASEB J. 26, 2930–2940. doi: 10.1096/fj.11-200295
Wade, A., Robinson, A. E., Engler, J. R., Petritsch, C., James, C. D., and Phillips, J. J.
(2013). Proteoglycans and their roles in brain cancer. FEBS J. 280, 2399–2417.
doi: 10.1111/febs.12109
Wang, Z., Wang, B., Yang, L., Guo, Q., Aithmitti, N., Songyang, Z., et al. (2009).
Presynaptic and postsynaptic interaction of the amyloid precursor protein
promotes peripheral and central synaptogenesis. J. Neurosci. 29, 10788–10801.
doi: 10.1523/JNEUROSCI.2132-09.2009
Wasco, W., Bupp, K., Magendantz, M., Gusella, J. F., Tanzi, R. E., and Solomon, F.
(1992). Identification of a mouse brain cDNA that encodes a protein related
to the Alzheimer disease-associated amyloid beta protein precursor. Proc. Natl.
Acad. Sci. U S A 89, 10758–10762. doi: 10.1073/pnas.89.22.10758
Wasco, W., Gurubhagavatula, S., Paradis, M. D., Romano, D. M., Sisodia, S. S.,
Hyman, B. T., et al. (1993). Isolation and characterization of APLP2 encoding
a homolog of the Alzheimer’s associated amyloid beta protein precursor. Nat.
Genet. 5, 95–100. doi: 10.1038/ng0993-95
Weyer, S. W., Zagrebelsky, M., Herrmann, U., Hick, M., Ganss, L., Gobbert, J.,
et al. (2014). Comparative analysis of single and combined APP/APLP
knockouts reveals reduced spine density in APP-KO mice that is prevented
by APPsα expression. Acta Neuropathol. Commun. 2:36. doi: 10.1186/2051-59
60-2-36
Willem, M., Tahirovic, S., Busche, M. A., Ovsepian, S. V., Chafai, M.,
Kootar, S., et al (2015). η-Secretase processing of APP inhibits neuronal
activity in the hippocampus. Nature 526, 443–447. doi: 10.1038/nature
14864
Williamson, T. G., Mok, S. S., Henry, A., Cappai, R., Lander, A. D., Nurcombe, V.,
et al. (1996). Secreted glypican binds to the amyloid precursor protein of
Alzheimer’s disease (APP) and inhibits APP-induced neurite outgrowth. J. Biol.
Chem. 271, 31215–31221. doi: 10.1074/jbc.271.49.31215
Wu, S., and Barger, S. W. (2004). Induction of serine racemase by inflammatory
stimuli is dependent on AP-1. Ann. N Y Acad. Sci. 1035, 133–146.
doi: 10.1196/annals.1332.009
Wu, S., Basile, A. S., and Barger, S. W. (2007). Induction of serine
racemase expression and D-serine release from microglia by secreted
amyloid precursor protein (sAPP). Curr. Alzheimer Res. 4, 243–251.
doi: 10.2174/156720507781077241
Yuste, R. (2011). Dendritic spines and distributed circuits. Neuron 71, 772–781.
doi: 10.1016/j.neuron.2011.07.024
Yuste, R., and Bonhoeffer, T. (2004). Genesis of dendritic spines: insights
from ultrastructural and imaging studies. Nat. Rev. Neurosci. 5, 24–34.
doi: 10.1038/nrn1300
Yuste, R., and Bonhoeffer, T. (2001). Morphological changes in dendritic
spines associated with long-term synaptic plasticity. Annu. Rev. Neurosci. 24,
1071–1089. doi: 10.1146/annurev.neuro.24.1.1071
Zhang, Z., Song, M., Liu, X., Su Kang, S., Duong, D. M., Seyfried, N. T.,
et al. (2015). Delta-secretase cleaves amyloid precursor protein and
regulates the pathogenesis in Alzheimer’s disease. Nat. Commun. 6:8762.
doi: 10.1038/ncomms9762
Zheng, H., Jiang, M., Trumbauer, M. E., Sirinathsinghji, D. J., Hopkins, R.,
Smith, D. W., et al. (1995). β-Amyloid precursor protein-deficient mice
show reactive gliosis and decreased locomotor activity. Cell 81, 525–531.
doi: 10.1016/0092-8674(95)90073-x
Zou, C., Crux, S., Marinesco, S., Montagna, E., Sgobio, C., Shi, Y., et al. (2016).
Amyloid precursor protein maintains constitutive and adaptive plasticity of
dendritic spines in adult brain by regulating D-serine homeostasis. EMBO J.
35, 2213–2222. doi: 10.15252/embj.201694085
Zou, C., Montagna, E., Shi, Y., Peters, F., Blazquez-Llorca, L., Shi, S., et al.
(2015). Intraneuronal APP and extracellular Aβ independently cause dendritic
spine pathology in transgenic mouse models of Alzheimer’s disease. Acta
Neuropathol. 129, 909–920. doi: 10.1007/s00401-015-1421-4
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Montagna, Dorostkar and Herms. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Molecular Neuroscience | www.frontiersin.org 7 May 2017 | Volume 10 | Article 136
